Butterfly Needles: The Rising Demand for IV Catheters Propelling Growth of the Butterfly Needles Market
ButterfFly Needles Market |
The global Butterfly Needles
Market is estimated to be valued at US$
315.2 Mn in 2023 and is expected to exhibit a CAGR of 8.7% over the forecast period 2023 to 2030, as
highlighted in a new report published by Coherent Market Insights.
Market Overview:
Butterfly needles, also known as
winged infusion needles or blood collection needles, provide reliable
intravenous access for phlebotomy or intravenous therapy procedures. They
contain an integrated plastic "wings" to stabilize and anchor the
needle during insertion and stabilize the needle once inserted into the vein.
Their compact design and one-handed operation make them suitable for pediatric
patients and people with small, fragile or difficult to access veins.
Market key trends:
One of the key trends fueling the
growth of the butterfly needles market is the rising demand for intravenous
catheters and needles. According to the IV Team, approximately 46% of all
hospitalized patients in the United States receive some form of intravenous
therapy and more than 330 million intravenous devices are sold each year. Rapid
expansion of the healthcare industry, growing prevalence of chronic and
lifestyle diseases, and increasing number of surgical procedures are driving up
demand for IV catheters and associated devices such as butterfly needles.
Rising geriatric population, which is more prone to develop age-related
diseases, is also contributing to market growth.
Segment Analysis
The global butterfly needles
market is segmented based on product type, application, and end user. Based on
product type, the winged steel needle (also called plastic needle) segment
dominates the market due to ease of use and prevent injury while inserting into
patient's vein. The winged steel needle segment accounted for around 60% of the
global market share in 2023.
Key Takeaways
The Global
Butterfly Needles Market Size is expected to witness high growth,
exhibiting CAGR of 8.7% over the forecast
period, due to increasing prevalence of chronic diseases and rising geriatric
population prone to have venous access procedures.
Regional analysis - North America dominated the global butterfly
needles market in 2023 and is expected to continue its dominance over the
forecast period. This is attributed to presence of major players and rising
healthcare expenditure in the region. Asia Pacific exhibits the fastest growth
over the forecast period owing to increasing healthcare infrastructure and rising
medical tourism in countries like India and China.
Key players - Key players operating in the butterfly needles market
are Becton, Dickinson and Company, Kawasumi Laboratories Inc., Vygon SA,
Medline Industries Inc., ISOMed, Terumo Corporation, HTL Strefa, Cardinal
Health, iLife Medical Devices Pvt. Ltd., and AdvaCare Pharma. Becton, Dickinson
and Company held around 25% of the global market share in 2023 due to its
diversified product portfolio and large geographical presence across the globe.
Read more
https://www.dailyprbulletin.com/butterfly-needles-market-size-share-growth-outlook-2023/
Comments
Post a Comment